| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PD | Common Stock | Options Exercise | $29,325 | +5,000 | +4.9% | $5.86* | 107,840 | 05 Apr 2023 | Direct | F1 |
| transaction | PD | Common Stock | Sale | $158,000 | -5,000 | -4.6% | $31.60 | 102,840 | 05 Apr 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PD | Stock Option (Right to buy) | Options Exercise | $0 | -5,000 | -5% | $0.000000 | 95,000 | 05 Apr 2023 | Common Stock | 5,000 | $5.86 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | A portion of these shares represent restricted stock units. |
| F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.37 to $31.72 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The option becomes exercisable as follows: (a) with respect to the Incentive Stock Option shares, 17,050 of the shares first becomes exercisable on the Date of Grant, an additional 17,050 of the shares first becomes exercisable on January 1 in each of 2018, 2019 and 2020, and the remaining 10,417 shares first become exercisable on January 1, 2021; and (b) with respect to the Nonstatutory Stock Option shares, all of the 21,383 shares first becomes exercisable on the Date of Grant. |